The relationship between human viruses and lymphoma aetiology and pathogenesis is both fascinating and complex. This special series will comprehensively cover the spectrum of unique clinicopathological lymphoma entities in which viruses are aetiologically implicated. This series aims to provide an updated overview of the most clinically and scientifically important data and to offer future perspectives.
Preface: virus-associated lymphomas
Epstein-Barr virus-associated lymphoproliferative disorders in immunosuppressed patients
The contribution of ebv to the pathogenesis of classical hodgkin lymphoma
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants
Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrence
Narrative review of chronic active EBV infection—advances in clinical management
From pathobiology to targeted treatment in Epstein Barr virus related T cell and Natural Killer cell lymphoproliferative diseases
Adoptive cellular immunotherapy for Epstein-Barr virus-associated lymphoproliferative disease
HIV-associated lymphoma—advances in clinical management
Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management
Disclosure
The series “Lymphoma and Viruses” was commissioned by the editorial office, Annals of Lymphoma without any sponsorship or funding. CPF and CSL served as the unpaid Guest Editors for the series.